KLF4 is a tumor suppressor gene, and mTOR is a proto-oncogene, so we speculate that overexpressed mTOR is not conducive to the prognosis of patients with sarcoma; the effect of KLF4 should be just the opposite. The gene discussed is MTOR; the disease is sarcoma.